← Back to Search

Other

Topical Powder for Rosacea

Phase 2
Waitlist Available
Research Sponsored by Dermata Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks

Summary

This trial is testing a new powder medication for people with moderate to severe acne rosacea. They want to see if it is safe and effective.

Eligible Conditions
  • Rosacea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy as measured by Investigator Global Assessment (IGA)
Efficacy as measured by lesion counts
Secondary study objectives
Incidence of adverse events as a measure of safety and tolerability

Trial Design

2Treatment groups
Experimental Treatment
Group I: Study Treatment 2Experimental Treatment1 Intervention
Placebo powder mixed with Hydrogen Peroxide
Group II: Study Treatment 1Experimental Treatment1 Intervention
DMT310 Powder mixed with Hydrogen Peroxide

Find a Location

Who is running the clinical trial?

Dermata TherapeuticsLead Sponsor
5 Previous Clinical Trials
983 Total Patients Enrolled
1 Trials studying Rosacea
107 Patients Enrolled for Rosacea
~45 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top